Skip to main content
. Author manuscript; available in PMC: 2009 Sep 14.
Published in final edited form as: Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2008 May 16;15(5):627–641. doi: 10.1080/13825580802036936

Table 1.

Baseline characteristics for study subjects with cognitive testing (n = 853) by the presence of the metabolic syndrome

Variable With the metabolic syndrome* (n = 112, 13.1%) Without the metabolic syndrome* (n = 741, 86.9%) p Value
Age (years) 61.8 ± 8.2 60.8 ± 8.9 .28
Gender .17
 Male 47 (42.0%) 261 (35.2%)
 Female 65 (58.0%) 480(64.8%)
Race/Ethnicity .009
 Non-Hispanic White 64 (57.1%) 486 (65.6%)
 Non-Hispanic Black 15 (13.4%) 83 (11.2%)
 Hispanic 25 (22.3%) 87 (11.7%)
 Asian/Pacific Island/Native American 8 (7.1%) 85 (11.5%)
Educational level .25
 High school or less 16 (14.3%) 80 (10.8%)
 Some college 39 (34.8%) 210 (28.3%)
 Bachelor’s degree 25 (22.3%) 192 (25.9%)
 Graduate/professional degree 32 (28.6%) 259 (34.9%)
Household income .23
 Low 32 (28.6%) 165 (22.4%)
 Medium 15 (13.4%) 115 (15.6%)
 Moderate 24 (21.4%) 140 (19.0%)
 High 41 (36.6%) 317 (43.0%
Current/Former smoker 44 (39.3%) 290 (39.2%) .98
Body-mass index (kg/m2) 32.6 ± 5.1 26.7 ± 4.7 <.0001
Blood pressure (mmHg)
 Systolic 132.4 ± 15.5 123.7 ± 16.6 <.0001
 Diastolic 81.9 ± 10.2 77.9 ± 10.0 <.0001
Total cholesterol (mg/dL) 221.0 ± 32.9 220.7 ± 37.1 .92
LDL cholesterol (mg/dL) 136.1 ± 29.4 137.0 ± 34.5 .77
HDL cholesterol (mg/dL)§ 46.3 ± 10.6 61.5 ± 16.0 <.0001
Triglycerides (mg/dL)§ 194.5 ± 72.1 110.8 ± 57.9 <.0001
Glucose (mg/dL)|| 109.3 ± 12.8 96.8 ± 9.2 <.0001
CES-D score 11.3 ± 9.2 11.8 ± 8.6 .51
Current use of anti-hypertensives 23 (20.5%) 102 (13.8%) .06
Current use of statins 42 (37.5%) 120 (16.2%) <.0001
*

Mean ± SD or number (%).

p Value for comparison of subjects with the metabolic syndrome to subjects without the metabolic syndrome.

n=851.

§

n=852.

||

n=848.